Publications by authors named "Giusi Blanco"

Claim this Profile
T
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center.
Vittorio Oteri, Fiorenza Gianì, Giulia Sapuppo, Stefania Panebianco, Ilenia Marturano, Giusi Blanco

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dostarlimab in elderly patients with multiple comorbidities and allergic diathesis: case report.
Katia Lanzafame, Giusi Blanco, Marco D'Asta, Mirella Sapienza, Giulia Maria Bonanno

AME Case Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort Study.
Sabrina Paratore, Angela Russo, Giusi Blanco, Katia Lanzafame, Eliana Giurato

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of High-Ozonide Oil in Prevention of Cancer Relapses Mechanisms and Clinical Evidence.
Alberto Izzotti, Enzo Fracchia, Camillo Rosano, Antonio Comite, Liliana Belgioia, Giusi Blanco

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis.
Vittorio Gebbia, Marco Maria Aiello, Giuseppe Banna, Giusi Blanco, Livio Blasi

Ecancermedicalscience· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Domenica Lorusso, Alessandra Bologna, Sabrina Chiara Cecere, Elisabetta De Matteis, Giusy Scandurra, Giusi Blanco

Support Care Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin efficacy based on type of metastatic site: a real-life study in heavily pretreated metastatic breast cancer.
Angela Prestifilippo, Daniele Grippaldi, Giusi Blanco, Lorenzo Memeo, Ivana Puliafito

Future Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.
Emilio Bajetta, Laura Catena, Nicola Fazio, Sara Pusceddu, Pamela Biondani, Giusi Blanco

Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis